4. Disease Statistics

Cardiovascular, lung, and blood diseases constitute a large morbidity, mortality, and economic burden on individuals, families, and the Nation.  Common forms are atherosclerosis, hypertension, COPD, and blood-clotting disorders—embolisms and thromboses.  The most serious atherosclerotic diseases are CHD, as manifested by heart attack and angina pectoris, and cerebrovascular disease, as manifested by stroke.

In 2008, cardiovascular, lung, and blood diseases accounted for 1,052,000 deaths and 43 percent of all deaths in the United States (p. 35).  The estimated economic cost in 2008 for these diseases was $392 billion, 22 percent of the total economic costs of illness, injuries, and death (p. 51).  Of all diseases, heart disease is the leading cause of death; chronic lower respiratory diseases (CLRD), which includes COPD and asthma, ranks third (behind cancer); and cerebrovascular disease is fourth (p. 38).  Cardiovascular and lung diseases account for 3 of the 4 leading causes of death (p. 38) and 4 of the 10 leading causes of infant death (p. 44).  Hypertension, asthma, CHD, and COPD are especially prevalent and account for substantial morbidity in Americans (p. 47).

The purpose of the biomedical research conducted by the NHLBI is to contribute to the prevention and treatment of cardiovascular, lung, and blood diseases and sleep disorders.  National disease statistics show that by mid-century, morbidity and mortality from these diseases had reached record high levels.  Since then, however, substantial improvements have been achieved, especially over the past 40 years, as shown by the significant decline in mortality rates.  Because many of these diseases begin early in life, their early detection and control can reduce the risk of disability and can delay death.  Although important advances have been made in the treatment and control of cardiovascular, lung, and blood diseases, these diseases continue to be a major burden on the Nation.

Mortality statistics in this chapter are for diseases or conditions classified as the underlying cause of death.  Heart failure, however, is never truly an underlying cause even though 56,830 deaths in 2008 were nominally coded to it as the underlying cause.  Therefore, in this chapter, mortality statistics attributed to any mention of heart failure represent it as either the underlying cause or a contributing cause of death.

Cardiovascular Diseases

  • In 2008, CVD caused 812,000 deaths—33 percent of all deaths (p. 35).
  • Heart disease is the leading cause of death; the main form, CHD, caused 405,000 deaths in 2008 (pp. 36, 38).
  • The annual number of deaths from CVD increased substantially from 1900 to 1970 and remains high (p. 37). 
  • The death rate (not age-adjusted) for CVD increased from 1920 until it peaked in 1968.  Since then, the trend has been downward.  In 2008, the rate was below the all-time low in 1900 (p. 37).
  • Cerebrovascular disease, the fourth leading cause of death, accounted for 134,000 deaths in 2008 (pp. 36, 38).
  • Heart disease is second only to all cancers combined in years of potential life lost (p. 38).
  • Heart disease is the leading cause of death in blacks and Hispanics, but second to cancer in Asians and American Indians.  Stroke ranks as the third or fourth leading cause of death in the minority groups, except in American Indians, where it ranks seventh (p. 38).
  • Deaths with heart failure as the underlying or contributing cause increased from 1970 to 1993 and then remained constant to 2008 (p. 39).
  • From 1999 to 2008, death rates for CHD and stroke declined in males and females of all racial/ethnic groups.  CHD mortality remained highest in the black population and lowest in the Asian population.  Stroke mortality continues to be highest in the black population (p. 40).
  • Because of the rapid decline in mortality from CHD since the peak in 1968, there were 1,174,000 fewer deaths from CHD in 2008 than would have occurred if there had been no decline (p. 41). 
  • Substantial improvements have been made in the treatment of CVD.  Since 1975 or 1985, the percent of hospitalizations for AMI, stroke, heart failure, and cardiac dysrhythmias that were discharged dead declined appreciably (p. 41).
  • The decline in CHD mortality began earlier in the United States than in most countries and outpaced that in most countries until the 1990s (only selected countries are shown) (p. 42).
  • From 1999 to 2008, the percentage decline in death rates for CHD and stroke was fairly similar for whites and blacks (p. 43).
  • In 2008, an estimated 82.6 million persons in the United States had CVD, including 76.4 million with hypertension and 16.3 million with CHD (p. 47).
  • Since the 1960s, there has been a substantial reduc­tion in the prevalence of CVD risk factors:  hyper­tension, smoking, and high cholesterol, but not overweight.  The large decline in prevalence of hypertension from 1976–1980 to 1988–1994 was fol­lowed by a slightly higher prevalence in 1999–2004 and 2005–2008 (p. 48).
  • From 1976–1980 to 2005–2008, the percentage of persons with hypertension who were aware of their condition, on treatment for it, and having their blood pressure under control increased substantially (p. 49).
  • A 2005–2008 national survey showed only about 48 percent of hypertensive patients (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg or on antihypertensive medication) had their condition under control (p. 49).
  • Hospitalization rates for heart failure in those aged 45 to 64 years increased from 1971 to 1993 and remained stable to 2009.  Rates for those aged 65 years and older increased from 1971 to 1998 and remained relatively stable until 2005; rates then declined through 2009 (p. 50).
  • The estimated economic cost of CVD for 2008 was $298 billion:
    • $179 billion in direct health expenditures
    • $118 billion in indirect cost of mortality (p. 51).

Lung Diseases

  • Lung diseases, excluding lung cancer, caused an estimated 242,000 deaths in 2008 (p. 35).
  • CLRD caused 141,000 deaths in 2008 and is the third leading cause of death (pp. 36, 38).
  • From 1999 to 2008, death rates for asthma declined in both black and white males and females; death rates for COPD declined in both black and white males but rose in both black and white females (p. 43).
  • From 1980 to 2008, infant death rates for various lung diseases declined markedly (p. 43).
  • In 2008, of the 10 leading causes of infant mortality, 4 were lung diseases or had a lung disease component (p. 44).  From 1998 to 2008, changes in mortality for the causes were:
    • Congenital malformations (-9 percent)
    • Disorders of short gestation (-3 percent)
    • Sudden infant death syndrome (-27 percent)
    • Respiratory distress syndrome (-51 percent).
  • In 2008, approximately one in six deaths in children under 1 year of age was due to a lung disease (p. 44).
  • From 1980 to 2008, the CLRD death rate for females in the United States increased appreciably compared with the rates in several other countries (p. 45).
  • From 2000 to 2008, death rates for CLRD decreased slightly for Asian and Hispanic females but were stable for American Indian and non-Hispanic white and non-Hispanic black females.  For males, the rates decreased in all racial/ethnic groups (p. 46).
  • Among the sleep disorders, sleep apnea is increasingly being recognized as an important health problem, which can lead to serious consequences.  From 2000 to 2009, physician office visits for sleep apnea increased from 2 to 3.7 million (p. 46).
  • Asthma is a common chronic condition, particularly in children (pp. 47, 48, 50). 
  • The economic cost of asthma, COPD, and pneumonia was $89 billion in 2008:
    • $68 billion in direct health expenditures
    • $21 billion in indirect cost of mortality (p. 51).

Blood Diseases

  • Approximately 10,000 deaths were attributed to blood diseases in 2008 (p. 35).  These include the following:
    •    5,000 due to anemias
    •    1,800 due to coagulation defects
    •    800 due to purpura
    •    2,400 due to other blood diseases.
  • A large proportion of deaths from AMI, cerebrovascular disease, and peripheral artery disease involve blood-clotting problems (no estimate available). 
  • In 2008, anemias cost the Nation’s economy $6 billion:
    • $5 billion in direct health expenditures
    • $1 billion in indirect cost of mortality (p. 51).

Deaths From All Causes and Deaths From Cardiovascular, Lung, and Blood Diseases, U.S., 1988 and 2008

Cause of Death 1988 Number of Deaths 1988 Percent of Total 2008 Number of Deaths 2008 Percent of Total
All Causes 2,167,999 100 2,471,984 100
All Cardiovascular, Lung, and Blood Diseases
1,181,646 55 1,051,502 43
Cardiovascular Diseases
979,788 45 811,940 33
Blood
8,649 <1 10,066 <1
Lung
205,798* 9 242,350** 10
All Other Causes 986,353 45 1,420,482 57

* Includes 12,931 CVD deaths due to pulmonary heart disease.
** Includes 12,854 CVD deaths involving pulmonary heart disease.
Source:  Vital Statistics of the United States, National Center for Health Statistics (NCHS). 

 

Deaths by Major Causes, U.S., 2008
Deaths From Cardiovascular, Lung, and Blood Diseases, U.S., 2008
Death by Major Causes
Text-only with data points
Deaths from Cardiovascular, Lung, and Blood Diseases
Text-only with data points
*Excludes 12,854 deaths from pulmonary heart disease (0.5%).
Source:  Vital Statistics of the United States, NCHS. 
 

Deaths From Specific Cardiovascular, Lung, and Blood Diseases, U.S., 2008

Cause of Death Cardiovascular
Deaths (Thousands)
Lung
Deaths (Thousands)
Blood
Deaths (Thousands)
Acute Myocardial Infarction 134 —*
Other Coronary Heart Disease 270
Cerebrovascular Diseases (Stroke) 134 —*
Other Atherosclerosis 28
Pulmonary Embolism 7 7** —*
Deep Vein Thrombosis 2   —*
Other Cardiovascular Diseases 236 6**
Bleeding and Red Blood Cell Diseases 10
Chronic Obstructive Pulmonary Disease 138
Asthma 3
Influenza and Pneumonia 56
Neonatal Pulmonary Disorders 4
Interstitial Lung Diseases 7
Lung Diseases Due to External Agents 18
Other Lung Diseases 3
Total 812 242 10

* Deaths from pulmonary disorders also included as CVD.
** Deaths from anemias, coagulation defects, purpura, and other blood diseases.  Deaths attributed to blood-clotting diseases classified to AMI, stroke, and peripheral artery disease are not included.
†Most deaths from this cardiovascular disease can be classified as a blood-clotting disease.  No good estimate is available.
‡Numbers do not sum to the total due to rounding.
Note: Total, excluding overlap, is 1,051,502.
Source:  Vital Statistics of the United States, NCHS.

Deaths From Cardiovascular Diseases, U.S., 2008
Deaths From Lung Diseases, U.S., 2008
Deaths From Blood Diseases, U.S., 2008
Deaths from Cardiovascular Diseases
Text-only with data points
Deaths from Lung Diseases
Text-only with data points
Deaths from Blood Diseases
Text-only with data points

* Includes heart failure, cardiac dysrhythmias, hypertensive disease, deep vein thrombosis, and other heart and blood vessel diseases.
Note: Numbers do not sum to 100 percent due to rounding.
Source: Vital Statistics of the United States, NCHS.

Deaths From Cardiovascular Diseases, U.S., 1900–2008

Deaths from Cardiovascular Diseases
Text-only with data points

Source: Vital Statistics of the United States, NCHS.

Death Rates* for Cardiovascular Diseases, U.S., 1900–2008

Death Rates for Cardiovascular Disease
Text-only with data points

*Not age-adjusted.
Source: Vital Statistics of the United States, NCHS.

Ten Leading Causes of Death: Death Rates, U.S., 2008

10 Leading Causes of Death
Text-only with data points

*  Not age-adjusted.
** Includes 133.3 deaths per 100,000 population from CHD.
† CLRD is the term used in the ICD/10 for COPD and asthma.
‡Based on the average remaining years of life up to age 77 years.
Note: Diseases shown in bold are those addressed in Institute programs.
Source: Vital Statistics of the United States, NCHS.

Ten Leading Causes of Death Among Minority Groups, U.S., 2008

10 Leading Causes of Death Among Minority Groups-Blacks
Text-only with data points
10 Leading Causes of Death Among Minority Groups-Hispanics
Text-only with data points
10 Leading Causes of Death Among Minority Groups-Asians
Text-only with data points
10 Leading Causes of Death Among Minority Groups-American Indians
Text-only with data points

* Includes deaths among individuals of Asian extraction and Asian-Pacific Islanders.
** Includes deaths among Aleuts and Eskimos.
Note: Causes of death shown in bold are those addressed in Institute programs.
Source: Vital Statistics of the United States, NCHS.

Age Adjusted Death Rates for Cardiovascular and Noncardiovascular Diseases, U.S., 1963, 1988, and 2008

Cause of Death Deaths/100,000 Population* Percent Change 1963-2008 Percent Change 1988-2008
1963 1988 2008
All Causes 1,346 975 760 -44 -22
Cardiovascular Diseases
805 450 245 -70 -46
Coronary Heart Disease
478 234 123 -74 -48
Stroke
174 74** 41 -77 -45
Other
153 142 81 -47 -43
Noncardiovascular Diseases
541 525 515 -5 -2
COPD and Asthma
16 38 44 167 16
Other
524 487 471 -10 -3

*  Age-adjusted.
**  ICD 10/9 comparability ratio (1.0502) applied.
ICD 10/9 comparability ratio (1.0411) applied.
Source: Vital Statistics of the United States, NCHS.

Deaths Attributed to Heart Failure,* U.S., 1970–2008

Deaths From Heart Failure
Text-only with data points

* Heart failure as the underlying cause of death or otherwise mentioned on the death certificate.
Note: Breaks in trend line indicate change in ICD codes.
Source: Vital Statistics of the United States, NCHS.

Age-Adjusted Death Rates for Coronary Heart Disease by Race/Ethnicity and Sex, U.S., 1999–2008

Death Rates for Heart Disease by Race/Ethnicity and Sex
Text-only with data points
*Non-Hispanic.
Source: Vital Statistics of the United States, NCHS.

Age-Adjusted Death Rates for Stroke by Race/Ethnicity and Sex, U.S., 1999–2008

Death Rates for Stroke by by Race/Ethnicity and Sex
Text-only with data points
*Non-Hispanic.
Source: Vital Statistics of the United States, NCHS.

Age-Adjusted Death Rates for Coronary Heart Disease, U.S., 1950–2008
Actual Rate and Expected Rates if Rise Had Continued or Reached a Plateau

Death Rates for Coronary Heart Disease
Text-only with data points

Source: Vital Statistics of the United States, NCHS.

Common Cardiovascular and Lung Diseases With High Percentage Discharged Dead From Hospitals, U.S., 1975, 1985, and 2009

Common Cardiovascular and Lung Disease With High Percentage Discharged Dead From Hospitals
Text-only with data points

Source: National Hospital Discharge Survey (NHDS), NCHS.

Death Rates* for Coronary Heart Disease in Males, Ages 35–74, in Selected Countries, 1970–2009

Death Rates for Coronary Heart Disease in Males Ages 35-74
Text-only with data points

* Age-adjusted to the European Standard Population.
** United Kingdom for 2008 and 2009; England and Wales for 1970–2007.
Source: World Health Organization (WHO) Mortality Database.

Death Rates* for Coronary Heart Disease in Females, Ages 35–74, in Selected Countries, 1970–2009

Death Rates for Coronary Heart Disease in Females Ages 35-74 years
Text-only with data points

* Age-adjusted to the European Standard Population.
** United Kingdom for 2008 and 2009; England and Wales for 1970–2007.
Source: WHO Mortality Database.

Percent Change in Age-Adjusted Death Rates for Selected Causes by Race and Sex, U.S., 1999–2008

Change in Death Rates for Selected Causes by Race and Sex
Text-only with data points

Source: Vital Statistics of the United States, NCHS.

Death Rates for Lung Diseases in Infants, U.S., 1980–2008

Death Rates for Lung Diseases in Infants
Text-only with data points

Source: Vital Statistics of the United States, NCHS.

Ten Leading Causes of Infant Mortality, U.S., 2008

10 Leading Causes of Infant Mortality
Text-only with data points

* Congenital CVD and congenital respiratory diseases accounted for 44.6 deaths under age 1 per 100,000 live births (black bar), which is 34 percent of infant deaths due to all congenital malformations.
** From 1998 to 2008, congenital CVD declined 30 percent; congenital malformations of the respiratory system declined 47 percent; other congenital malformations increased 20 percent.
NA: Not available.
Note: Diseases shown in bold are those addressed in Institute programs.
Source: Vital Statistics of the United States, NCHS.

Deaths Under Age 1 Year Due to Cardiovascular and Lung Diseases, U.S., 2008

Cause of Death Deaths Under Age 1 Deaths Under Age 1 Year Due to Cardiovascular and Lung Diseases
Text-only with data points
All Causes 28,059
Cardiovascular Diseases 2,121
Congenital Malformations
1,527
Other
594
Lung Diseases
4,718
Sudden Infant Death Syndrome
2,353
Respiratory Distress Syndrome
640
Pneumonia
210
Bronchopulmonary Dysplasia (BPD)
217
Atelectasis of Newborn
335
Congenital Malformations
371
Other Lung Diseases
592
Other Diseases 21,220

Note: Diseases shown in bold are those addressed in Institute programs.
Source: Vital Statistics of the United States, NCHS.

Death Rates* for Chronic Lower Respiratory Diseases in Males, Ages 35 Years and Older, in Selected Countries, 1980–2009

Death Rates* for Chronic Lower Respiratory Diseases in Males Ages 35+ Years
Text-only with data points

* Age-adjusted to the European Standard Population.
** United Kingdom for 2008 and 2009; England and Wales for 1970–2007
Source: WHO Mortality Database.

Death Rates* for Chronic Lower Respiratory Diseases in Females, Ages 35 Years and Older, in Selected Countries, 1980–2009

Death Rates* for Chronic Lower Respiratory Diseases in Females Ages 35+ Years
Text-only with data points

* Age-adjusted to the European Standard Population.
** United Kingdom for 2008 and 2009; England and Wales for 1970–2007
Source: WHO Mortality Database.

Age-Adjusted Death Rates for Chronic Lower Respiratory Diseases by Race/Ethnicity and Sex, U.S., 1999–2008

Age-Adjusted Death Rates for Chronic Lower Respiratory Diseases by Race/Ethnicity and Sex
Text-only with data points

* Non-Hispanic.
Source: Vital Statistics of the United States, NCHS.

Physician Office Visits for Sleep Disorders, U.S., 2000–2009

Physician Office Visits for Sleep Disorders
Text-only with data points

Note: Primary and secondary diagnoses.
Source: National Ambulatory Medical Care Survey, NCHS.

Prevalence of Common Cardiovascular and Lung Diseases, U.S., 2005–2010

Disease Number of Persons
Cardiovascular Diseases* 82,600,000
Hypertension** 76,400,000
Coronary Heart Disease 16,300,000
Heart Failure 5,700,000
Stroke 7,000,000
Congenital Heart Disease 1,000,000
Asthma 39,190,000
COPD§ 12,481,000

*  Includes hypertension, CHD, stroke, or heart failure for ages 20 years and older.
**  Hypertension is defined as systolic blood pressure ≥ 140 mmHg, or diastolic blood pressure ≥ 90 mmHg, or being on antihypertensive medication, or being told twice of having hypertension.
† Range from 650,000 to 1,300,000 for ages 18 years and older (Am Heart J 2004;147:425–439).
‡ 25,710,000 still have asthma and of those, 13,882,000 have had an attack in the past 12 months, for all ages.
§ An estimated 12,481,000 diagnosed (2010) and 12,000,000 undiagnosed (2006), for ages 18 years and older.
Sources: National Health and Nutrition Examination Survey (NHANES) 2005–2008, NCHS and National Health Interview Survey (NHIS) 2010, NCHS.

Prevalence of Cardiovascular Diseases* in Adults by Age and Sex, U.S., 2005-2008

Prevalence of Cardiovascular Diseases* in Adults by Age and Sex
Text-only with data points

*  Hypertension, CHD, stroke, or heart failure. Hypertension is defined as systolic blood pressure ≥ 140 mmHg, or diastolic blood pressure ≥ 90 mmHg, or being on antihypertensive medication.
Source: NHANES, 2005–2008, NCHS.

Prevalence of Common Cardiovascular and Lung Diseases by Age, U.S., 2005–2010

Prevalence of Common Cardiovascular and Lung Diseases by Age
Text-only with data points

Source: NHIS and NHANES, NCHS.

Age-Adjusted Prevalence of Cardiovascular Disease Risk Factors in Adults, U.S., 1961–2010

Age-Adjusted Prevalence of Cardiovascular Disease Risk Factors in Adults
Text-only with data points

Notes: Hypertension is defined as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg, or being on antihypertensive medication. High cholesterol is ≥240 mg/dL. Overweight is BMI ≥25 kg/m2. Data were collected at six time periods: 1960–1961 (plotted at 1961), 1971–1974 (plotted at 1972), 1976–1980 (plotted at 1978), 1988–1994 (plotted at 1991), 1999–2004 (plotted at 2004), and 2005–2008 (plotted at 2008).
Sources: NHIS for smoking, ages ≥18, NCHS; NHANES for the other risk factors, ages 20–74, NCHS.

Hypertensive* Population Aware, Treated, and Controlled, Ages 18 and Older, U.S., 1976–1980 to 2005–2008

Hypertensive Population Aware, Treated, and Controlled, Age 18+
Text-only with data points

*  Hypertension is defined as systolic blood pressure ≥ 140 mm Hg, or diastolic blood pressure > 90 mm Hg, or being on antihypertensive medication.
Source: NHANES, NCHS.

Adult Population With Hypertension* by Age, Race/Ethnicity, and Sex, U.S., 2005–2008

Adult Population With Hypertension* by by Age, Race/Ethnicity, and Sex
Text-only with data points

*   Hypertension is systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, or being on antihypertensive medication.
** Non-Hispanic.
Sources: NHANES, NCHS.

Hospitalization Rates for Heart Failure, Ages 45–64 and 65 and Older, U.S., 1971–2009

Hospitalization Rates for Heart Failure, Ages 4564 Years and 65+ Years
Text-only with data points

Source: NHDS, NCHS.

Prevalence of Asthma Episodes in Previous 12 Months by Age, U.S., 1997–2010

Persons Experiencing Asthma Episodes in Previous 12 Months by Age
Text-only with data points

Source: NHIS, NCHS.

Direct and Indirect Economic Costs of Illness by Major Diagnosis, U.S., 2008

  Amount (Dollars in Billions) Direct Cost* Amount (Dollars in Billions) Indirect Cost of Mortality** Amount (Dollars in Billions) Total Percent Distribution Direct Cost Percent Distribution Indirect Cost of Mortality Percent Distribution
Total
Cardiovascular Diseases $179.3 $118.4 $297.7 15.6% 19.9% 17.1%
COPD, Asthma, Pneumonia 67.7 21.0 88.7 5.9 3.5 5.1
Anemias and Other Deficiencies 4.7 1.2 5.9 0.4 0.2 0.3
Subtotal 251.7 140.6 392.3 21.9 23.6 22.5
Neoplasms 77.4 124.0 201.5 6.7 20.9 11.5
Injury and Poisoning 77.7 101.6 179.3 6.8 17.1 10.3
Endocrine, Nutritional, and Metabolic Diseases 102.3 22.6 124.9 8.9 3.8 7.2
Diseases of the Digestive System 84.2 28.6 112.8 7.3 4.8 6.5
Diseases of the Respiratory System 78.5 27.4 105.9 6.8 4.6 6.1
Diseases of the Musculoskeletal System 117.8 3.0 120.9 10.2 0.5 6.9
Diseases of the Nervous System 69.7 15.4 85.2 6.1 2.6 4.9
Mental Disorders 72.1 8.2 80.3 6.3 1.4 4.6
Diseases of the Genitourinary System 55.5 7.7 63.2 4.8 1.3 3.6
Infectious and Parasitic Diseases 16.2 23.9 40.1 1.4 4.0 2.3
Normal Live Birth 34.6 34.6 3.0 2.0
Diseases of the Skin 24.2 0.7 24.9 2.1 0.1 1.4
Other and Not Linked to Specific Condition 155.8 111.8 267.7 13.6 18.8 15.3
Total  $1,150.0  $594.8  $1,744.8 100% 100% 100%

* Direct costs are personal health care expenditures for hospital and professional services care, prescribed medications, and home care reported by the Medical Expenditure Panel Survey (MEPS), Agency for Healthcare Research and Quality (AHRQ), by diagnosis, excluding nursing home care costs and costs due to comorbidities. 
** The mortality cost for each disease group was estimated for 2008 by multiplying the number of deaths by age, sex, and cause of death in 2008 by the 2007 present value of lifetime earnings (latest available) discounted at 3 percent and projected to 2008 based on a 2008 inflation factor measured from mean earnings reported by the U.S. Census Bureau.  
Includes costs for COPD, asthma, and pneumonia.
Note: Estimates are not available for total lung diseases and blood clotting disorders.
Source: Prepared by NHLBI from direct costs on the MEPS Web site; numbers of deaths from Vital Statistics of the United States, NCHS; present value of lifetime earnings from the Institute for Health and Aging, University of California; and mean earnings from the U.S. Census Bureau.

Total Economic Costs of the Leading Diagnostic Groups, U.S., 2008

Total Economic Costs of the Leading Diagnostic Groups
Text-only with data points

Source: MEPS, AHRQ.

Direct Economic Cost and Percent Distribution for Selected Conditions by Type of Service, U.S., 2008

  Percent Distribution by Type of Service
Condition Total Direct Cost (in Billions) Hospital Outpatient or Office-Based Provider Visits Hospital Inpatient Stays Emergency Room Visits Prescribed Medicines Home Health
Heart Disease $95.6 18.0% 56.5% 7.6% 10.2% 8.0%
COPD, Asthma 53.7 24.6 24.4 5.7 38.0 7.4
Hypertension 47.4 27.5 13.1 3.6 45.0 10.8
Hyperlipidemia 38.6 23.4 3.5 0.3 70.3 2.6
Stroke 18.8 9.5 48.3 4.9 6.2 31.0
Other Circulatory Conditions 17.6 26.6 59.3 5.1 4.1 4.9
Pneumonia 14.0 5.4 85.3 4.0 1.9 3.4
Anemias 4.7 22.8 67.9 0.7 4.2 4.4

Source:  MEPS, Household Component Summary Data Tables, AHRQ.

 

Back to Top

« Fact Book Table of Contents

Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon